Stay updated on Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 on the page. It appears to be a software/content management update rather than a modification to the study details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedFooter shows Revision: v3.3.3; the HHS Vulnerability Disclosure link and the Revision: v3.3.2 notice have been removed.SummaryDifference0.1%

- Check60 days agoChange DetectedEditorial updates to the Publications section clarify publication sourcing, and the revision version was updated.SummaryDifference0.1%

- Check67 days agoChange DetectedThe government funding status notice was removed from the page; core study content and sections such as eligibility, interventions, and outcomes are unchanged.SummaryDifference0.3%

- Check81 days agoChange DetectedOnly minor formatting changes are apparent in the updated page, with core study details, outcomes, and eligibility criteria unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check109 days agoChange Detected- Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference2%

Stay in the know with updates to Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.